IPG Photonics Corp IPGP
Deals with insiders in the proxy filed Apr 1, 2026
Proxy, Item 404Deals between IPGP and its directors, executives, owners of more than 5% or their families: a relative on the payroll, a plane the company charters from its CEO, a director's company that buys from it. SEC rules (Item 404) make the company list every such deal over $120,000 in its proxy statement.
New this year
Compared with Apr 7, 2025
Paragraphs about a deal, a person or a relative with nothing like them in the proxy filed Apr 7, 2025.
Transactions with Related Parties“On February 20, 2025, we entered into a Registration Rights Letter with The Valentin Gapontsev Trust I and The Valentin Gapontsev Trust III (the “Gapontsev Trusts”) pursuant to which we agreed to register with the SEC an aggregate of 2,150,000 shares of common stock held by the Gapontsev Trusts. The Gapontsev Trusts collectively are a significant stockholder of the Company. See Common Stock Ownership below. Such shares were not eligible to be resold under registration statement exemptions under Rule 144 promulgated under the Securities Act of 1933, as amended. The Gapontsev Trusts paid the Company for all incurred expenses of the registration of such shares pursuant to the Registration Rights Letter, including SEC filing fees and the fees and expenses of the Company’s counsel and independent registered public accountants.”
Read it in the proxyopen_in_new
Transactions with Related Parties“Compensation of Dr. Igor Samartsev. Dr. Igor Samartsev has served as our Senior Vice President, Chief Scientist since February 2022. Dr. Samartsev is the spouse of Natalia Pavlova, a director of the Company. The Compensation Committee approves compensation of all executive officers, including that of Dr. Samartsev. The Audit Committee has also reviewed and approved Dr. Samartsev's compensation in accordance with our related person transaction policy. In fiscal 2025, Dr. Samartsev received total compensation of $1,050,480, consisting of (i) base salary of $440,516, (ii) a cash bonus of $143,400 paid in 2025 in respect of fiscal 2024 performance, and (iii) equity awards having a grant‑date fair value of $466,564 granted in 2025.”
Read it in the proxyopen_in_new
No longer reported 1 paragraph of the proxy filed Apr 7, 2025 with nothing like them this year
Board Practices, Policies and Processes“From time to time, certain institutional investors may become beneficial owners of 5% or more of the voting securities of the Company and, as a result, are considered a related person under the policy. These organizations may provide services to the Company or its benefit plans. In 2024, participants in our 401(k) Retirement Plan paid approximately $132,400 in fees to affiliates of The Vanguard Group representing expense ratios associated with the Vanguard investment funds in the 401(k) Retirement Plan.”
Read it in last year's proxyopen_in_new
The whole section
As filed
6 paragraphs quoted as filed
Transactions with Related Parties“The Board adopted a written related person transaction policy that requires the Audit Committee to approve or ratify any transaction or series of transactions exceeding $120,000 in which our Company is a participant and any related person has a direct or indirect material interest (other than solely as a result of being a director or trustee or less than 10% owner of another entity) ("Related Party Transactions"). Related persons include our directors, director nominees and officers and their immediate family members and persons sharing their households. It also includes persons controlling more than 5% of our outstanding common stock. Subject to certain exceptions in the policy, related parties are required to notify the Audit Committee of the Related Party Transaction for an assessment of whether the transaction or proposed transaction should be permitted. Management also has established procedures for monitoring transactions that could be subject to approval or ratification under the Related Party Transactions policy.”
Read it in the proxyopen_in_new
Transactions with Related Parties“In deciding whether to approve or ratify the Related Party Transaction, the Audit Committee considers relevant facts and circumstances. The committee takes into account, among other factors, whether the transaction is on terms no more favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related person’s interest in the transaction. Once a Related Party Transaction has been identified, the Audit Committee reviews all of the relevant facts and circumstances and approves or disapproves entry into the transaction. Members of the Audit Committee having an interest in a transaction excuse themselves for the consideration and approval of the transaction in which they have an interest. Certain transactions are exempt from the policy including compensation paid by the Company for service as a director or an officer which is approved by the Compensation Committee or the Board (except for executive officers who are an immediate family member of another executive officer or director of the Company, in which case the Audit Committee also must approve the compensation arrangements).”
Read it in the proxyopen_in_new
Transactions with Related Parties“The Audit Committee reviewed and approved the following 2025 Related Party Transactions in compliance with our policy:”
Read it in the proxyopen_in_new
Transactions with Related Parties“On February 20, 2025, we entered into a Registration Rights Letter with The Valentin Gapontsev Trust I and The Valentin Gapontsev Trust III (the “Gapontsev Trusts”) pursuant to which we agreed to register with the SEC an aggregate of 2,150,000 shares of common stock held by the Gapontsev Trusts. The Gapontsev Trusts collectively are a significant stockholder of the Company. See Common Stock Ownership below. Such shares were not eligible to be resold under registration statement exemptions under Rule 144 promulgated under the Securities Act of 1933, as amended. The Gapontsev Trusts paid the Company for all incurred expenses of the registration of such shares pursuant to the Registration Rights Letter, including SEC filing fees and the fees and expenses of the Company’s counsel and independent registered public accountants.”
Read it in the proxyopen_in_new
Transactions with Related Parties“Compensation of Dr. Igor Samartsev. Dr. Igor Samartsev has served as our Senior Vice President, Chief Scientist since February 2022. Dr. Samartsev is the spouse of Natalia Pavlova, a director of the Company. The Compensation Committee approves compensation of all executive officers, including that of Dr. Samartsev. The Audit Committee has also reviewed and approved Dr. Samartsev's compensation in accordance with our related person transaction policy. In fiscal 2025, Dr. Samartsev received total compensation of $1,050,480, consisting of (i) base salary of $440,516, (ii) a cash bonus of $143,400 paid in 2025 in respect of fiscal 2024 performance, and (iii) equity awards having a grant‑date fair value of $466,564 granted in 2025.”
Read it in the proxyopen_in_new
Transactions with Related Parties“Pursuant to our Corporate Governance Guidelines, we expect each of our directors to ensure that other existing and future commitments do not conflict with or materially interfere with his or her service as a director. In addition, directors are required to inform the chair of the NCGC and the Chair of the Board prior to joining the board of another public company to ensure that any potential conflicts, excessive time demands or other issues are carefully considered.”
Read it in the proxyopen_in_new
Paragraphs are compared by their words, not read by AI: one counts as new when no paragraph last year shares half of its words, or when it names a person or company last year's section did not. A deal reported again with a new amount is not new. Always check the filing. Open the proxy ↗ · Last year's proxy ↗
Sources
The related-party section (Item 404) of the latest annual proxy statement (DEF 14A), against last year's, compared by their words.
Also
CEO pay: the same proxy's pay versus performance table.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IPGP/export.csv") into a cell.